Early Identification and Action in CKD
| Status: | Active, not recruiting |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | September 2014 |
| End Date: | March 2016 |
Chronic kidney disease (CKD) is highly prevalent and associated with significantly increased
risk of cardiovascular morbidity and end-stage renal disease. Evidence from randomized
clinical trials suggests that treating urinary albumin excretion (UAE), dyslipidemia, and
hypertension will reduce these risks. Unfortunately, less than 30% of the CKD population is
screened and treated according to recommended guidelines. Using a cluster-randomized,
controlled design and clinic-embedded pharmacists, this pilot pragmatic trial will randomize
6 Geisinger primary care clinics (72 patients) to usual care (group 1) or a
pharmacist-directed "CKD Action Plan" (group 2). Determining the impact of the CKD Action
Plan on screening and treatment guideline adherence is the primary goal of this pilot study.
risk of cardiovascular morbidity and end-stage renal disease. Evidence from randomized
clinical trials suggests that treating urinary albumin excretion (UAE), dyslipidemia, and
hypertension will reduce these risks. Unfortunately, less than 30% of the CKD population is
screened and treated according to recommended guidelines. Using a cluster-randomized,
controlled design and clinic-embedded pharmacists, this pilot pragmatic trial will randomize
6 Geisinger primary care clinics (72 patients) to usual care (group 1) or a
pharmacist-directed "CKD Action Plan" (group 2). Determining the impact of the CKD Action
Plan on screening and treatment guideline adherence is the primary goal of this pilot study.
Inclusion Criteria:
- 18 years of age or older
- eGFRCR value between 45-59 ml/min/1.73m2 in the prior 12 months
- scheduled laboratory appointment for serum creatinine testing within the next 30 days
- average systolic or diastolic blood pressure reading of at least 150 or 85 mm Hg,
respectively, during the prior 12 months.
Exclusion Criteria:
- fewer than 2 blood pressure readings in the prior 12 months,
- pregnancy
- current hospitalization
- life expectancy less than 6 months as determined by the study investigators
We found this trial at
1
site
Click here to add this to my saved trials
